Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection

Clinical and Experimental Immunology

Volumn 176, Issue 2, 2014, Pages 283-290

  Chandel, H S ^a   Pandey, S P ^a   Shukla, D ^a   Lalsare, K ^a   Selvaraj, S K ^a   Jha, M K ^a   Saha, B ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

CD40; Leishmania; Macrophages; Toll like receptor

Indexed keywords

ANTIBODY; CD40 ANTIBODY; CD40 ANTIGEN; GAMMA INTERFERON; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; CPG ODN 2216; MITOGEN ACTIVATED PROTEIN KINASE; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CD40; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LEISHMANIA; METABOLISM; PARASITOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CD40; LEISHMANIA; MACROPHAGES; TOLL-LIKE RECEPTOR;

AMINOQUINOLINES; ANIMALS; ANTIGENS, CD40; BLOTTING, WESTERN; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; LEISHMANIA MAJOR; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; RECEPTOR CROSS-TALK; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 84897934197     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12264     Document Type: Article

References (32)

1. Bauer S, Müller T, Hamm S. Pattern recognition by Toll-like receptors. Adv Exp Med Biol 2009; 653:15-34.
2. Martinez J, Huang X, Yang Y. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLOS Pathog 2010; 6:e1000811.
3. Janeway CA Jr, Medzhitov R. Lipoproteins take their toll on the host. Curr Biol 1999; 9:R879-882.
4. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-995.
5. Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005; 438:364-368.
6. Schwartz RH. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 1985; 3:237-261.
7. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11:191-212.
8. Banchereau J, Bazan F, Blanchard D etal. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12:881-922.
9. Campbell KA, Ovendale PJ, Kennedy MK etal. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996; 4:283-289.
10. Kamanaka M, Yu P, Yasui T etal. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996; 4:275-281.
11. Soong L, Xu JC, Grewal IS etal. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 1996; 4:263-273.
12. Awasthi A, Mathur R, Khan A etal. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. J Exp Med 2003; 197:1037-1043.
13. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 2004; 10:540-544.
14. Rub A, Dey R, Jadhav M etal. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 2009; 10:273-280.
15. Qiu Y, Ding Y, Zou L etal. Divergent roles of amino acid residues inside and outside the BB loop affect human Toll-like receptor (TLR)2/2, TLR2/1 and TLR2/6 responsiveness. PLOS One 2013; 8:e61508.
16. Uematsu S, Akira S. Toll-Like receptors (TLRs) and their ligands. Handb Exp Pharmacol 2008; 183:1-20.
17. Hornung V, Barchet W, Schlee M, Hartmann G. RNA recognition via TLR7 and TLR8. Handb Exp Pharmacol 2008; 183:71-86.
18. Jin MS, Lee JO. Structures of the Toll-like receptor family and its ligand complexes. Immunity 2008; 29:182-191.
19. Smith KD, Ozinsky A. Toll-like receptor-5 and the innate immune response to bacterial flagellin. Curr Top Microbiol Immunol 2002; 270:93-108.
20. Zeytun A, Chaudhary A, Pardington P, Cary R, Gupta G. Induction of cytokines and chemokines by Toll-like receptor signaling: strategies for control of inflammation. Crit Rev Immunol 2010; 30:53-67.
21. Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V. Toll-like receptors and leishmaniasis. Infect Immun 2008; 76:866-872.
22. Murugaiyan G, Agrawal R, Mishra GC, Mitra D, Saha B. Functional dichotomy in CD40 reciprocally regulates effector T cell functions. J Immunol 2006; 177:6642-6649.
23. Sudan R, Srivastava N, Pandey SP, Majumdar S, Saha B. Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness. J Immunol 2012; 188:2328-2337.
24. Martin S, Agarwal R, Murugaiyan G, Saha B. CD40 expression levels modulate regulatory T cells in Leishmania donovani infection. J Immunol 2010; 185:551-559.
25. Srivastava N, Sudan R, Saha B. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate L. major infection. J Immunol 2011; 186:5863-5872.
26. Liew FY, Wei XQ, Proudfoot L. Cytokines and nitric oxide as effector molecules against parasitic infections. Phil Trans R Soc Lond B Biol Sci 1997; 352:1311-1315.
27. Chan SH, Perussia B, Gupta JW etal. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991; 173:869-879.
28. Launois P, Tacchini-Cottier F, Parra-Lopez C, Louis JA. Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. Int Rev Immunol 1998; 17:157-180.
29. Srivastava S, Pandey SP, Jha MK, Chandel HS, Saha B. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. Clin Exp Immunol 2013; 172:403-409.
30. Vargas-Inchaustegui DA, Tai W, Xin L, Hogg AE, Corry DB, Soong L. Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice. Infect Immun 2009; 77:2948-2956.
31. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994; 263:235-237.
32. Bogdan C, Röllinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 2000; 173:17-26.